한글목차

바이오프로세스 자동화 시장의 규모는 최근 급속히 확대하고 있습니다. 2025년 64억 달러에서 2026년에는 72억 1,000만 달러로, CAGR 12.6%로 성장이 전망되고 있습니다. 지난 수년간의 성장은 바이오의약품 제조의 확대, 생물제제 생산의 복잡성, 프로그래밍 가능한 제어 시스템 도입, 일관된 제품 품질에 대한 수요, 임상 제조 업무의 확대에 기인하는 것으로 보입니다.

바이오프로세스 자동화 시장의 규모는 향후 수년간 급성장이 전망됩니다. 2030년에는 115억 2,000만 달러에 달하며, CAGR은 12.4%에 달할 전망입니다. 예측 기간 중의 성장은 연속 바이오프로세스에 대한 투자 증가, 확장 가능한 자동화 플랫폼에 대한 수요 증가, 세포 및 유전자 치료 제조의 성장, AI 기반 공정 최적화의 통합, 스마트 바이오 제조 시설의 확장에 기인할 것으로 예측됩니다. 예측 기간 중 주요 동향으로는 자동화 바이오프로세스 제어 플랫폼의 도입 확대, 실시간 프로세스 분석의 통합 증가, 일회용 바이오프로세싱 자동화의 보급 확대, 폐쇄형 프로세스 제어 시스템의 확대, 데이터 무결성 및 컴플라이언스 강화 등을 들 수 있습니다.

맞춤형 의료의 보급 확대는 향후 수년간 바이오프로세스 자동화 시장의 성장을 촉진할 것으로 예측됩니다. 맞춤형 의료는 환자 개개인의 특성에 맞게 의료 판단, 치료법, 중재 방안을 맞춤화하는 것입니다. 바이오프로세스 자동화는 환자별 치료제를 정밀하고 확장성 있게 생산할 수 있도록 함으로써 이러한 접근 방식을 지원합니다. 예를 들어 2024년 2월 미국 헬스케어 단체인 'Personalised Medicine Coalition'이 발표한 바에 따르면 미국 식품의약국(FDA)은 2023년 희귀질환 환자를 위한 16개의 새로운 개인맞춤형 치료제를 승인했으며, 이는 2022년 6건에서 증가한 수치입니다. 년의 6건에서 증가했습니다. 그 결과, 맞춤형 의료 증가는 바이오프로세스 자동화 솔루션에 대한 수요를 촉진하고 있습니다.

바이오프로세스 자동화 시장의 주요 기업은 바이오 리액터와 같은 혁신적인 기술을 개발하여 바이오프로세스 운영의 효율성을 높이고 있습니다. 바이오리액터는 생물학적, 화학적 반응을 위한 제어 환경을 제공하는 설계 시스템입니다. 예를 들어 2023년 4월, 치료제 개발 및 제조를 지원하는 미국 기술 기업 사이티바(Cytiva)는 일회용 업스트림 바이오프로세스을 간소화하는 X 플랫폼 바이오 리액터를 발표했습니다. 50L와 200L 용량으로 출시되는 이 바이오리액터는 조작이 쉽고 유연하며, 인체공학적 개선, 생산 능력 향상, 공급망 운영 간소화를 통해 공정 효율을 향상시킵니다. 이들은 세포 및 유전자 치료, 바이러스 벡터, 단클론 항체(mAbs) 제조에 사용할 수 있습니다.

목차

제1장 개요

제2장 시장의 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 용도 산업의 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의에 의한 공급망에 대한 영향, Covid가 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계의 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 시장의 세계 TAM(Total Addressable Market)

제9장 시장 세분화

제10장 지역별·국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자환경

제36장 경쟁 구도와 기업 개요

제37장 기타 대기업과 혁신적 기업

제38장 세계의 시장 경쟁 벤치마킹과 대시보드

제39장 주요 합병과 인수

제40장 시장의 잠재력이 높은 국가, 부문, 전략

제41장 부록

영문목차

Bioprocess automation is using automated systems to monitor and control the bioprocessing workflow, which involves living cells, organisms, or components to produce biological products such as biopharmaceuticals. Biopharmaceutical businesses use bioprocess automation for better process control and optimization, higher product quality, decreased variability, increased throughput and efficiency, cost savings, and scalability.

The main components of bioprocess automation are sensors, actuators, and controllers. Sensors are devices that detect and respond to inputs from the physical environment, converting them into electronic signals, which are used to monitor various parameters such as temperature, pH, dissolved oxygen, and pressure. The scale of operation includes preclinical operations, clinical operations, and commercial operations with batch, fed-batch, and perfusion modes of compatibility with bioprocessing systems include single-use systems, stainless steel, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Tariffs are affecting the bioprocess automation market by increasing costs of imported sensors, control valves, automation software licenses, industrial controllers, and analytical instruments used in biopharmaceutical manufacturing. Commercial-scale bioprocessing facilities in North America and Europe are most impacted due to reliance on imported automation components, while Asia-Pacific faces cost pressures on system exports. These tariffs are raising system integration costs and slowing automation upgrades. At the same time, they are supporting localized production of automation hardware, regional software development, and partnerships focused on compliant and cost-efficient bioprocess control solutions.

The main components of bioprocess automation are sensors, actuators, and controllers. Sensors are devices that detect and respond to inputs from the physical environment, converting them into electronic signals, which are used to monitor various parameters such as temperature, pH, dissolved oxygen, and pressure. The scale of operation includes preclinical operations, clinical operations, and commercial operations with batch, fed-batch, and perfusion modes of compatibility with bioprocessing systems include single-use systems, stainless steel, and others.

The bioprocess automation market size has grown rapidly in recent years. It will grow from $6.4 billion in 2025 to $7.21 billion in 2026 at a compound annual growth rate (CAGR) of 12.6%. The growth in the historic period can be attributed to growth of biopharmaceutical manufacturing, increasing complexity of biologics production, adoption of programmable control systems, demand for consistent product quality, expansion of clinical manufacturing operations.

The bioprocess automation market size is expected to see rapid growth in the next few years. It will grow to $11.52 billion in 2030 at a compound annual growth rate (CAGR) of 12.4%. The growth in the forecast period can be attributed to increasing investments in continuous bioprocessing, rising demand for scalable automation platforms, growth of cell and gene therapy manufacturing, integration of AI-driven process optimization, expansion of smart biomanufacturing facilities. Major trends in the forecast period include increasing adoption of automated bioprocess control platforms, rising integration of real-time process analytics, growing use of single-use bioprocessing automation, expansion of closed-loop process control systems, enhanced focus on data integrity and compliance.

The rising prevalence of personalized medicines is expected to drive growth in the bioprocess automation market in the coming years. Personalized medicine tailors healthcare decisions, treatments, and interventions to the unique characteristics of individual patients. Bioprocess automation supports this approach by enabling precise, scalable production of patient-specific therapies. For example, in February 2024, the Personalised Medicine Coalition, a US-based healthcare organization, reported that the FDA approved 16 new personalized treatments for rare disease patients in 2023, up from six approvals in 2022. As a result, the growing number of personalized medicines is fueling demand for bioprocess automation solutions.

Leading companies in the bioprocess automation market are developing innovative technologies, such as bioreactors, to streamline bioprocessing operations. A bioreactor is an engineered system that provides a controlled environment for biological and chemical reactions. For instance, in April 2023, Cytiva, a US-based technology company supporting therapeutic development and manufacturing, launched X-platform bioreactors to simplify single-use upstream bioprocessing. Offered initially in 50 and 200 L capacities, these bioreactors are easy to operate, flexible, and improve process efficiency through ergonomic enhancements, increased production capability, and simplified supply chain operations. They can be used to manufacture cell and gene therapies, viral vectors, and monoclonal antibodies (mAbs).

In September 2025, Thermo Fisher Scientific, a US-based life sciences and biopharma supplies leader, acquired the purification and filtration business of Solventum for an undisclosed amount. This acquisition enables Thermo Fisher to strengthen its bioprocess automation portfolio by expanding downstream processing capabilities, offering more comprehensive solutions for biologics, cell therapies, and drug manufacturing. Solventum's purification and filtration business provides critical filtration technologies across multiple geographies.

Major companies operating in the bioprocess automation market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Parker-Hannifin Corporation, Rockwell Automation Inc., Agilent Technologies Inc., Lonza Group AG, Waters Corporation, Getinge AB, Eppendorf SE, Repligen Corporation, BIONET Engineering, Pierre Guerin Technologies, Bioengineering AG, Genedata AG, ILS Automation LLC, INFORS HT AG, Synthace Ltd., Automated Control Concepts Inc., BlueSens gas sensor GmbH, Securecell AG, Flownamics Analytical Instruments Inc., PendoTECH LLC, Sartorius Stedim Biotech S.A.

North America was the largest region in the bioprocess automation market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bioprocess automation market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the bioprocess automation market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The bioprocess automation market includes revenues earned by entities by providing services such as process automation, instrumentation and control systems, training and support services, and maintenance and upgrades. The market value includes the value of related goods sold by the service provider or included within the service offering. The bioprocess automation market also includes sales of bioreactors, fermenters, laboratory information management systems (LIMS), and integrated bioprocess platforms. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Bioprocess Automation Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses bioprocess automation market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for bioprocess automation ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The bioprocess automation market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Component Of Process Control System: Sensors; Actuators; Controllers
• 2) By Scale Of Operation: Preclinical Operations; Clinical Operations; Commercial Operations
• 3) By Mode Of Operation: Batch; Fed-Batch; Perfusion
• 4) By Compatibility With Bioprocessing Systems: Single-Use Systems; Stainless Steel; Other Bioprocessing Systems
• Subsegments:
• 1) By Sensors: Temperature Sensors; Pressure Sensors; Flow Sensors; Level Sensors; PH Sensors; Other Sensors
• 2) By Actuators: Electric Actuators; Pneumatic Actuators; Hydraulic Actuators; Other Actuators
• 3) By Controllers: Programmable Logic Controllers (PLC); Distributed Control Systems (DCS); Supervisory Control And Data Acquisition (SCADA); Other Controllers
• Companies Mentioned: Thermo Fisher Scientific Inc.; Danaher Corporation; Merck KGaA; Parker-Hannifin Corporation; Rockwell Automation Inc.; Agilent Technologies Inc.; Lonza Group AG; Waters Corporation; Getinge AB; Eppendorf SE; Repligen Corporation; BIONET Engineering; Pierre Guerin Technologies; Bioengineering AG; Genedata AG; ILS Automation LLC; INFORS HT AG; Synthace Ltd.; Automated Control Concepts Inc.; BlueSens gas sensor GmbH; Securecell AG; Flownamics Analytical Instruments Inc.; PendoTECH LLC; Sartorius Stedim Biotech S.A.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Bioprocess Automation Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Bioprocess Automation Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Bioprocess Automation Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Bioprocess Automation Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Artificial Intelligence & Autonomous Intelligence
  • 4.1.2 Industry 4.0 & Intelligent Manufacturing
  • 4.1.3 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.1.4 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.5 Biotechnology, Genomics & Precision Medicine
• 4.2. Major Trends
  • 4.2.1 Increasing Adoption Of Automated Bioprocess Control Platforms
  • 4.2.2 Rising Integration Of Real-Time Process Analytics
  • 4.2.3 Growing Use Of Single-Use Bioprocessing Automation
  • 4.2.4 Expansion Of Closed-Loop Process Control Systems
  • 4.2.5 Enhanced Focus On Data Integrity And Compliance

5. Bioprocess Automation Market Analysis Of End Use Industries

• 5.1 Biopharmaceutical Manufacturers
• 5.2 Biotechnology Companies
• 5.3 Contract Manufacturing Organizations
• 5.4 Research Laboratories
• 5.5 Clinical Manufacturing Facilities

6. Bioprocess Automation Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Bioprocess Automation Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Bioprocess Automation PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Bioprocess Automation Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Bioprocess Automation Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Bioprocess Automation Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Bioprocess Automation Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Bioprocess Automation Market Segmentation

• 9.1. Global Bioprocess Automation Market, Segmentation By Component Of Process Control System, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Sensors, Actuators, Controllers
• 9.2. Global Bioprocess Automation Market, Segmentation By Scale Of Operation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Preclinical Operations, Clinical Operations, Commercial Operations
• 9.3. Global Bioprocess Automation Market, Segmentation By Mode Of Operation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Batch, Fed-Batch, Perfusion
• 9.4. Global Bioprocess Automation Market, Segmentation By Compatibility With Bioprocessing Systems, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Single-Use Systems, Stainless Steel, Other Bioprocessing Systems
• 9.5. Global Bioprocess Automation Market, Sub-Segmentation Of Sensors, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Temperature Sensors, Pressure Sensors, Flow Sensors, Level Sensors, PH Sensors, Other Sensors
• 9.6. Global Bioprocess Automation Market, Sub-Segmentation Of Actuators, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Electric Actuators, Pneumatic Actuators, Hydraulic Actuators, Other Actuators
• 9.7. Global Bioprocess Automation Market, Sub-Segmentation Of Controllers, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Programmable Logic Controllers (PLC), Distributed Control Systems (DCS), Supervisory Control And Data Acquisition (SCADA), Other Controllers

10. Bioprocess Automation Market Regional And Country Analysis

• 10.1. Global Bioprocess Automation Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Bioprocess Automation Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Bioprocess Automation Market

• 11.1. Asia-Pacific Bioprocess Automation Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Bioprocess Automation Market, Segmentation By Component Of Process Control System, Segmentation By Scale Of Operation, Segmentation By Mode Of Operation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Bioprocess Automation Market

• 12.1. China Bioprocess Automation Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Bioprocess Automation Market, Segmentation By Component Of Process Control System, Segmentation By Scale Of Operation, Segmentation By Mode Of Operation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Bioprocess Automation Market

• 13.1. India Bioprocess Automation Market, Segmentation By Component Of Process Control System, Segmentation By Scale Of Operation, Segmentation By Mode Of Operation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Bioprocess Automation Market

• 14.1. Japan Bioprocess Automation Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Bioprocess Automation Market, Segmentation By Component Of Process Control System, Segmentation By Scale Of Operation, Segmentation By Mode Of Operation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Bioprocess Automation Market

• 15.1. Australia Bioprocess Automation Market, Segmentation By Component Of Process Control System, Segmentation By Scale Of Operation, Segmentation By Mode Of Operation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Bioprocess Automation Market

• 16.1. Indonesia Bioprocess Automation Market, Segmentation By Component Of Process Control System, Segmentation By Scale Of Operation, Segmentation By Mode Of Operation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Bioprocess Automation Market

• 17.1. South Korea Bioprocess Automation Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Bioprocess Automation Market, Segmentation By Component Of Process Control System, Segmentation By Scale Of Operation, Segmentation By Mode Of Operation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Bioprocess Automation Market

• 18.1. Taiwan Bioprocess Automation Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Bioprocess Automation Market, Segmentation By Component Of Process Control System, Segmentation By Scale Of Operation, Segmentation By Mode Of Operation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Bioprocess Automation Market

• 19.1. South East Asia Bioprocess Automation Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Bioprocess Automation Market, Segmentation By Component Of Process Control System, Segmentation By Scale Of Operation, Segmentation By Mode Of Operation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Bioprocess Automation Market

• 20.1. Western Europe Bioprocess Automation Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Bioprocess Automation Market, Segmentation By Component Of Process Control System, Segmentation By Scale Of Operation, Segmentation By Mode Of Operation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Bioprocess Automation Market

• 21.1. UK Bioprocess Automation Market, Segmentation By Component Of Process Control System, Segmentation By Scale Of Operation, Segmentation By Mode Of Operation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Bioprocess Automation Market

• 22.1. Germany Bioprocess Automation Market, Segmentation By Component Of Process Control System, Segmentation By Scale Of Operation, Segmentation By Mode Of Operation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Bioprocess Automation Market

• 23.1. France Bioprocess Automation Market, Segmentation By Component Of Process Control System, Segmentation By Scale Of Operation, Segmentation By Mode Of Operation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Bioprocess Automation Market

• 24.1. Italy Bioprocess Automation Market, Segmentation By Component Of Process Control System, Segmentation By Scale Of Operation, Segmentation By Mode Of Operation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Bioprocess Automation Market

• 25.1. Spain Bioprocess Automation Market, Segmentation By Component Of Process Control System, Segmentation By Scale Of Operation, Segmentation By Mode Of Operation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Bioprocess Automation Market

• 26.1. Eastern Europe Bioprocess Automation Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Bioprocess Automation Market, Segmentation By Component Of Process Control System, Segmentation By Scale Of Operation, Segmentation By Mode Of Operation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Bioprocess Automation Market

• 27.1. Russia Bioprocess Automation Market, Segmentation By Component Of Process Control System, Segmentation By Scale Of Operation, Segmentation By Mode Of Operation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Bioprocess Automation Market

• 28.1. North America Bioprocess Automation Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Bioprocess Automation Market, Segmentation By Component Of Process Control System, Segmentation By Scale Of Operation, Segmentation By Mode Of Operation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Bioprocess Automation Market

• 29.1. USA Bioprocess Automation Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Bioprocess Automation Market, Segmentation By Component Of Process Control System, Segmentation By Scale Of Operation, Segmentation By Mode Of Operation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Bioprocess Automation Market

• 30.1. Canada Bioprocess Automation Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Bioprocess Automation Market, Segmentation By Component Of Process Control System, Segmentation By Scale Of Operation, Segmentation By Mode Of Operation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Bioprocess Automation Market

• 31.1. South America Bioprocess Automation Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Bioprocess Automation Market, Segmentation By Component Of Process Control System, Segmentation By Scale Of Operation, Segmentation By Mode Of Operation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Bioprocess Automation Market

• 32.1. Brazil Bioprocess Automation Market, Segmentation By Component Of Process Control System, Segmentation By Scale Of Operation, Segmentation By Mode Of Operation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Bioprocess Automation Market

• 33.1. Middle East Bioprocess Automation Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Bioprocess Automation Market, Segmentation By Component Of Process Control System, Segmentation By Scale Of Operation, Segmentation By Mode Of Operation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Bioprocess Automation Market

• 34.1. Africa Bioprocess Automation Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Bioprocess Automation Market, Segmentation By Component Of Process Control System, Segmentation By Scale Of Operation, Segmentation By Mode Of Operation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Bioprocess Automation Market Regulatory and Investment Landscape

36. Bioprocess Automation Market Competitive Landscape And Company Profiles

• 36.1. Bioprocess Automation Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Bioprocess Automation Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Bioprocess Automation Market Company Profiles
  • 36.3.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Parker-Hannifin Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Rockwell Automation Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Bioprocess Automation Market Other Major And Innovative Companies

• Agilent Technologies Inc., Lonza Group AG, Waters Corporation, Getinge AB, Eppendorf SE, Repligen Corporation, BIONET Engineering, Pierre Guerin Technologies, Bioengineering AG, Genedata AG, ILS Automation LLC, INFORS HT AG, Synthace Ltd., Automated Control Concepts Inc., BlueSens gas sensor GmbH

38. Global Bioprocess Automation Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Bioprocess Automation Market

40. Bioprocess Automation Market High Potential Countries, Segments and Strategies

• 40.1 Bioprocess Automation Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Bioprocess Automation Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Bioprocess Automation Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer